Dalton Einhorn
Geen lopende functies
Loopbaan van Dalton Einhorn
Eerdere bekende functies van Dalton Einhorn
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Directeur/Bestuurslid | - | - |
| GENOCEA BIOSCIENCES, INC. | Directeur/Bestuurslid | 31-03-2011 | - |
Johnson & Johnson Innovation - JJDC, Inc.
 Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Private Equity Investor | 17-01-2011 | - |
| DAIICHI SANKYO CO., LTD. | Corporate Officer/Principal | - | - |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Corporate Officer/Principal | - | - |
Latterell Venture Partners
 Latterell Venture Partners Investment ManagersFinance Latterell Venture Partners (Latterell Venture Partners) is a venture capital firm founded in 2001 by Pat Latterell. The firm is headquartered in San Ramon, California. | Private Equity Investor | - | - |
Opleiding van Dalton Einhorn
| Yale University | Masters Business Admin |
| Drew University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 8 |
| Japan | 2 |
Operationeel
| Private Equity Investor | 2 |
| Corporate Officer/Principal | 2 |
| Director/Board Member | 2 |
Sectoraal
| Health Technology | 5 |
| Finance | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| DAIICHI SANKYO CO., LTD. | Health Technology |
| GENOCEA BIOSCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Latterell Venture Partners
Latterell Venture Partners Investment ManagersFinance Latterell Venture Partners (Latterell Venture Partners) is a venture capital firm founded in 2001 by Pat Latterell. The firm is headquartered in San Ramon, California. | Finance |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
Johnson & Johnson Innovation - JJDC, Inc.
Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Finance |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Health Technology |
- Beurs
- Insiders
- Dalton Einhorn
- Ervaring
